Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 892

1.

Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.

Michiels JJ, Budde U, van der Planken M, van Vliet HH, Schroyens W, Berneman Z.

Best Pract Res Clin Haematol. 2001 Jun;14(2):401-36. Review.

PMID:
11686107
[PubMed - indexed for MEDLINE]
2.

Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications.

Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, Budde U, van Vliet HH.

Semin Thromb Hemost. 2006 Sep;32(6):577-88. Review.

PMID:
16977568
[PubMed - indexed for MEDLINE]
3.

Atypical variant of acquired von Willebrand syndrome in Wilms tumor: is hyaluronic acid secreted by nephroblastoma cells the cause?

Michiels J, Schroyens W, Berneman Z, van der Planken M.

Clin Appl Thromb Hemost. 2001 Apr;7(2):102-5.

PMID:
11292185
[PubMed - indexed for MEDLINE]
4.

Clinical significance of inhibitors in acquired von Willebrand syndrome.

Mohri H, Motomura S, Kanamori H, Matsuzaki M, Watanabe S, Maruta A, Kodama F, Okubo T.

Blood. 1998 May 15;91(10):3623-9. Erratum in: Blood 1999 Jan 1;93(1):413.

PMID:
9572997
[PubMed - indexed for MEDLINE]
Free Article
5.

Acquired von Willebrand syndrome: features and management.

Mohri H.

Am J Hematol. 2006 Aug;81(8):616-23. Review.

PMID:
16823821
[PubMed - indexed for MEDLINE]
6.

Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.

Michiels JJ, van de Velde A, van Vliet HH, van der Planken M, Schroyens W, Berneman Z.

Semin Thromb Hemost. 2002 Apr;28(2):111-32.

PMID:
11992235
[PubMed - indexed for MEDLINE]
7.

Acquired von Willebrand syndrome--report of 10 cases and review of the literature.

Nitu-Whalley IC, Lee CA.

Haemophilia. 1999 Sep;5(5):318-26. Review.

PMID:
10583513
[PubMed - indexed for MEDLINE]
8.

Acquired von Willebrand disease in monoclonal gammapathies: effectiveness of high-dose intravenous gamma globulin.

Michiels JJ, van Vliet HH.

Clin Appl Thromb Hemost. 1999 Jul;5(3):152-7.

PMID:
10726000
[PubMed - indexed for MEDLINE]
9.

Laboratory diagnosis and molecular classification of von Willebrand disease.

Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ.

Acta Haematol. 2009;121(2-3):71-84. doi: 10.1159/000214846. Epub 2009 Jun 8. Review.

PMID:
19506352
[PubMed - indexed for MEDLINE]
10.

Acquired von Willebrand syndrome in systemic lupus erythematodes.

Michiels JJ, Schroyens W, van der Planken M, Berneman Z.

Clin Appl Thromb Hemost. 2001 Apr;7(2):106-12.

PMID:
11292186
[PubMed - indexed for MEDLINE]
11.

Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.

Michiels JJ, Gadisseur A, Budde U, Berneman Z, van der Planken M, Schroyens W, van de Velde A, van Vliet H.

Semin Thromb Hemost. 2005 Nov;31(5):577-601. Review.

PMID:
16276467
[PubMed - indexed for MEDLINE]
12.

Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine.

Michiels JJ, Schroyens W, Berneman Z, van der Planken M.

Clin Appl Thromb Hemost. 2001 Apr;7(2):113-5. Review.

PMID:
11292187
[PubMed - indexed for MEDLINE]
13.

Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.

Michiels JJ, van Vliet HH.

Acta Haematol. 2009;121(2-3):154-66. doi: 10.1159/000214856. Epub 2009 Jun 8. Review.

PMID:
19506362
[PubMed - indexed for MEDLINE]
14.

Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome.

Federici AB.

Hum Immunol. 2005 Apr;66(4):422-30. Review.

PMID:
15866707
[PubMed - indexed for MEDLINE]
15.

Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome.

Casonato A, Pontara E, Doria A, Bertomoro A, Cattini MG, Gambari PF, Girolami A.

Br J Haematol. 2002 Mar;116(4):899-904.

PMID:
11886398
[PubMed - indexed for MEDLINE]
16.

Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study.

Tiede A, Priesack J, Werwitzke S, Bohlmann K, Oortwijn B, Lenting P, Eisert R, Ganser A, Budde U.

J Thromb Haemost. 2008 Apr;6(4):569-76. doi: 10.1111/j.1538-7836.2008.02909.x. Epub 2008 Jan 17.

PMID:
18208537
[PubMed - indexed for MEDLINE]
18.
19.

Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.

Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.

Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. Review.

PMID:
17164493
[PubMed - indexed for MEDLINE]
20.

Diagnosis and therapeutic management in a patient with type 2B-like acquired von Willebrand syndrome.

Karger R, Weippert-Kretschmer M, Budde U, Kretschmer V.

Blood Coagul Fibrinolysis. 2011 Mar;22(2):144-7. doi: 10.1097/MBC.0b013e328342486a.

PMID:
21178586
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk